Shipped in a discreet, unmarked envelope with all required documents enclosed.
Product Sheet
Active Ingredient(s)
Drospirenone, Ethinyl Estradiol
Reference Brand
Yasmin
Product Origin
Generic Product
Reference Manufacturer
Bayer
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Women's Health
Product Category
Oral contraceptive
Pharmacological Class
Hormonal combination
Clinical Indications
Pregnancy prevention
Manufacturer Description
Designed for use as hormonal contraception to support pregnancy prevention via ovulation inhibition.
Mechanism of Action
It prevents pregnancy by stopping the release of an egg and altering the cervical mucus consistency.
Route of Administration
Oral
Onset Time
Within cycle
Duration
24 hours
Contraindications
History of blood clots
Severe Adverse Events
Thrombosis
Common Side Effects
Nausea, Breast tenderness
Uncommon Side Effects
Headache, Mood changes
Drug Interactions
Rifampin, St. John's wort
Pregnancy Safety Warnings
Do not use if pregnant.
Age Restrictions
Not for children.
Storage Guidelines
Store at room temperature.
Related Products
Levonorgestrel combinations
Information associated with Drospirenone with Ethinyl Estradiol is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
